This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Norman Sharpless, Director of the National Cancer Institute at the National Institutes of Health. They discuss the accelerated pace of discovery in cancer research driven by genomics, big data analytics and personalized oncology. He also stresses the need to address fragmented pockets of research for more rapid deployment of treatment breakthroughs.
This week, hosts Mark Masselli and Margaret Flinter speak with Noelle LaCharite Principal Program Manager for Applied AI and Cognitive Services at Microsoft, and one of the original voice ‘skills’ developers for Amazon’s Alexa. She talks about the promise of applied AI, machine learning and voice technology systems which enable coders, developers or anyone to create their own applications and voice skills to enhance and advance the health care experience.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Sue Sisley, internist, psychiatrist and President of the Scottsdale Research Institute which is conducting the nation’s only FDA-approved study on the efficacy of whole plant marijuana for treatment of PTSD. She discusses her ten-year quest to complete a randomized control trial on the use of cannabis as a potentially effective approach, and restrictions that pose a challenge to expansive scientific research.
This week hosts Mark Masselli and Margaret Flinter speak with Dr. Charles Alessi, Senior Advisor for Dementia Prevention at Public Health England, the UK’s equivalent of the CDC. Dr. Alessi talks about the prevention strategies being deployed across the UK to delay the onset of dementia, the lack of barriers to primary care services, and their recently announced Minister of Loneliness to confront this chronic health issue.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Leana Wen, newly appointed President of the Planned Parenthood Federation of American. Dr. Wen talks about successful interventions she launched as Baltimore’s Health Commissioner on opioids, maternal mortality and gun violence, planning to take her tough public health approach to addressing challenges to women’s health and reproductive rights in America.
This week, hosts Mark Masselli and Margaret Flinter speak with Edward Abrahams, President of the Personalized Medicine Coalition which supports the emerging science of precision medicine and the huge potential it holds for cost savings with pharmacogenomics, targeted therapies, and improved outcomes for patients and health systems. They discuss the Coalition’s upcoming summit at Harvard which will bring together policy makers, leading scientists, advocates and provider organizations to devise strategies for advancing precision medicine.